Clinical Trial: The impact of multi-omics integrated with artificial intelligence technology on the occurrence and development of macrovascular complications in type 2 diabetes mellitus. (China)

Posted On: 2026-09-07

China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The impact of multi-omics integrated with artificial intelligence technology on the occurrence and development of macrovascular complications in type 2 diabetes mellitus.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131572

Registration Time: 2026/09/04

Type: Observational study

Primary Sponsor: The First Affiliated Hospital of Kunming Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=300691

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: The impact of multi-omics integrated with artificial intelligence technology on the occurrence and development of macrovascular complications in type 2 diabetes mellitus. (China)